1. Wasserman PG, Savargaonkar P. Paragangliomas: classification, pathology, and differential diagnosis. Otolaryngol Clin North Am. 2001; 34(5):845–62. v-vi.
2. Young WF Jr. Paragangliomas: clinical overview. Ann N Y Acad Sci. 2006; 1073:21–9.
3. Martucci VL, Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer. 2014; 38(1):7–41.
4. Boedeker CC, Ridder GJ, Schipper J. Paragangliomas of the head and neck: diagnosis and treatment. Fam Cancer. 2005; 4(1):55–9.
5. Williams MD. Paragangliomas of the head and neck: an overview from diagnosis to genetics. Head Neck Pathol. 2017; 11(3):278–87.
6. Hayward N, Cousins V. Head and neck paraganglioma: medical assessment, management, and literature update. J Otorhinolaryngol Hear Balance Med. 2018; 1:4.
7. Walker PJ, Fagan PA. Catecholamine-secreting paraganglioma of the pterygopalatine fossa: case report. Am J Otol. 1993; 14(3):306–8.
8. Otokida K, Ohira A, Kamimura A, Fujimori M, Kato M, et al. Cervical cathecolamine-secreting paraganglioma in the pterygopalatine fossa. Tohoku J Exp Med. 1987; 153(4):347–54.
9. White JB, Link MJ, Cloft HJ. Endovascular embolization of paragangliomas: a safe adjuvant to treatment. J Vasc Interv Neurol. 2008; 1(2):37–41.
10. Tashi S, Purohit BS, Becker M, Mundada P. The pterygopalatine fossa: imaging anatomy, communications, and pathology revisited. Insights Imaging. 2016; 7(4):589–99.
11. DelGaudio JM. Endoscopic transnasal approach to the pterygopalatine fossa. Arch Otolaryngol Head Neck Surg. 2003; 129(4):441–6.
12. Hofstetter CP, Singh A, Anand VK, Kacker A, Schwartz TH. The endoscopic, endonasal, transmaxillary transpterygoid approach to the pterygopalatine fossa, infratemporal fossa, petrous apex, and the Meckel cave. J Neurosurg. 2010; 113(5):967–74.